FORMA THERAPEUTICS HOLDINGS, INC. Stock-Based Compensation
FORMA THERAPEUTICS HOLDINGS, INC. reported Stock-Based Compensation of $5.79 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-08-05
- FORMA THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2022-06-30 was $5.79M, a 9.87% decline year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2022-03-31 was $6.25M, a 62.53% increase year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2021-12-31 was $5.59M, a 136.51% increase year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $6.70M, a 214.75% increase year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2021 was $22.56M, a 224.23% increase from fiscal 2020.
- FORMA THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2020 was $6.96M, a 178.58% increase from fiscal 2019.
- FORMA THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2019 was $2.50M.
| Period end | Share-based Payment Arrangement, Expense 1 month | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | $5.79M 10-Q · filed 2022-08-05 | $12.04M 10-Q · filed 2022-08-05 | $17.63M derived: sum of 3 quarters · filed 2022-08-05 | $24.34M derived: sum of 4 quarters · filed 2022-08-05 | |
| 2022-03-31 | $6.25M 10-Q · filed 2022-05-06 | $11.85M derived: sum of 2 quarters · filed 2022-05-06 | $18.55M derived: sum of 3 quarters · filed 2022-05-06 | $24.97M derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-12-31 | $5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $12.29M derived: sum of 2 quarters · filed 2022-03-01 | $18.71M derived: sum of 3 quarters · filed 2022-08-05 | $22.56M 10-K · filed 2022-03-01 | |
| 2021-09-30 | $6.70M 10-Q · filed 2021-11-12 | $13.12M derived: sum of 2 quarters · filed 2022-08-05 | $16.97M 10-Q · filed 2021-11-12 | $19.34M derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-06-30 | $6.42M 10-Q · filed 2022-08-05 | $10.27M 10-Q · filed 2022-08-05 | $12.63M derived: sum of 3 quarters · filed 2022-08-05 | $14.76M derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-03-31 | $3.85M 10-Q · filed 2022-05-06 | $6.21M derived: sum of 2 quarters · filed 2022-05-06 | $8.34M derived: sum of 3 quarters · filed 2022-05-06 | $9.60M derived: sum of 4 quarters · filed 2022-05-06 | |
| 2020-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.49M derived: sum of 2 quarters · filed 2022-03-01 | $5.75M derived: sum of 3 quarters · filed 2022-03-01 | $6.96M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $2.13M 10-Q · filed 2021-11-12 | $3.38M derived: sum of 2 quarters · filed 2021-11-12 | $4.59M 10-Q · filed 2021-11-12 | $5.46M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $1.26M 10-Q · filed 2021-08-13 | $2.47M 10-Q · filed 2021-08-13 | $3.33M derived: sum of 3 quarters · filed 2021-08-13 | $3.70M derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $1.21M 10-Q · filed 2021-05-14 | $2.08M derived: sum of 2 quarters · filed 2021-05-14 | $2.45M derived: sum of 3 quarters · filed 2021-05-14 | $2.94M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $869.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $1.24M derived: sum of 2 quarters · filed 2021-03-30 | $1.73M derived: sum of 3 quarters · filed 2021-03-30 | $2.50M 10-K · filed 2021-03-30 | |
| 2019-11-30 | $200.00K 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | $368.00K 10-Q · filed 2020-11-12 | $865.00K derived: sum of 2 quarters · filed 2020-11-12 | $1.63M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $497.00K 10-Q · filed 2020-08-13 | $1.26M 10-Q · filed 2020-08-13 |